Subscribe to RSS

DOI: 10.1055/s-0044-1801316
Blood IgE and Eosinophils are not Reliable Predictors of Nasal Tissue Eosinophils in Chronic Rhinosinusitis with Nasal Polyposis
Authors
Funding The authors declare that they did not receive financial support from agencies in the public, private, or non-profit sectors to conduct the present study.
Abstract
Introduction Chronic rhinosinusitis with nasal polyposis (CRSwNP) is a chronic inflammatory condition of the paranasal sinuses that is mainly associated with type-2 inflammation. Immunoglobulin E (IgE) and eosinophils in blood and nasal tissue have been suggested as biomarkers for the prognosis and severity of CRSwNP as well as indications for biological treatment.
Objective The present study aims to assess the relationships between blood IgE concentration, blood eosinophil count, and nasal polyp eosinophil count in CRSwNP patients.
Methods The present study is retrospective. Nasal polyps from CRSwNP patients (n = 73) were fixed and embedded in paraffin for hematoxylin and eosin stain. Blood was collected to measure IgE concentration and eosinophil count.
Results Weak correlations were found between blood and tissue eosinophil counts (p = 0.004, r = 0.367) as well as blood IgE concentration and blood eosinophil count (p = 0.007, r = 0.372). There was no statistically significant correlation between blood IgE concentration and tissue eosinophil count. When dividing patients based on nasal polyp eosinophil count, blood eosinophil level was higher in the severely eosinophilic group than in the mildly eosinophilic group (p = 0.002).
Conclusion Blood IgE and eosinophils are not reliable biomarkers to predict the inflammatory condition in CRSwNP. Further research is needed on the clinical roles of these biomarkers.
Ethical Considerations
All procedures performed in this study were in accordance with the ethical standards of the institution of the University of British Columbia—Providence Health Care Research Ethics Board (H19-00249), University of São Paulo CAAE (82294118500005505), and the Declaration of Helsinki and International Conference on Harmonization Guidelines for Good Clinical Practice.
Publication History
Received: 21 February 2024
Accepted: 09 October 2024
Article published online:
15 April 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
Judy Fan, William Daniels, Athenea Pascual, Changwan Ryu, Masih Sarafan, Miguel Soares Tepedino, Richard Louis Voegels, Marco Aurélio Fornazieri, Don Sin, Rogério Pezato, Andrew Thamboo. Blood IgE and Eosinophils are not Reliable Predictors of Nasal Tissue Eosinophils in Chronic Rhinosinusitis with Nasal Polyposis. Int Arch Otorhinolaryngol 2025; 29: s00441801316.
DOI: 10.1055/s-0044-1801316
-
References
- 1 Kato A. Immunopathology of chronic rhinosinusitis. Allergol Int 2015; 64 (02) 121-130
- 2 Pezato R, Stamm AC, Douglas R. et al. Nasal disease with polyps: Need for clarity. Int Forum Allergy Rhinol 1829-1831;2023(Mar)
- 3 Maspero J, Adir Y, Al-Ahmad M. et al. Type 2 inflammation in asthma and other airway diseases. ERJ Open Res 2022; 8 (03) 00576-02021
- 4 Longino ES, Labby AB, Wu J. et al. Association of cytokine profile with prior treatment failure and revision surgery in chronic rhinosinusitis. Int Forum Allergy Rhinol 2023; 13 (01) 5-14
- 5 Gevaert P, Van Bruaene N, Cattaert T. et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol 2011; 128 (05) 989-95.e1 , 8
- 6 Gevaert P, Calus L, Van Zele T. et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol 2013; 131 (01) 110-6.e1
- 7 Bachert C, Desrosiers M, Mullol J. et al. A Randomized Phase 3 Study, Sinus-52, Evaluating the efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with Nasal Polyps. J Allergy Clin Immunol 2019; 143 (02) AB433
- 8 Staudacher AG, Peters AT, Kato A, Stevens WW. Use of endotypes, phenotypes, and inflammatory markers to guide treatment decisions in chronic rhinosinusitis. Ann Allergy Asthma Immunol 2020; 124 (04) 318-325
- 9 Fokkens WJ, Lund VJ, Hopkins C. et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology 2020; 58 (0, Suppl S29) 1-464
- 10 Gitomer SA, Fountain CR, Kingdom TT. et al. Clinical examination of tissue eosinophilia in patients with chronic rhinosinusitis and nasal polyposis. Otolaryngol Head Neck Surg 2016; 155 (01) 173-178
- 11 Wang K, Deng J, Yang M. et al. Concordant systemic and local eosinophilia relates to poorer disease control in patients with nasal polyps. World Allergy Organ J 2019; 12 (08) 100052
- 12 Aslan F, Altun E, Paksoy S, Turan G. Could Eosinophilia predict clinical severity in nasal polyps?. Multidiscip Respir Med 2017; 12 (01) 21
- 13 El-Anwar MW, Mobasher MA, Hindawy E. Assessment of the blood eosinophil count in different grades of nasal polyps. Egypt J Otolaryngol 2022; 38 (01) 82
- 14 Soler ZM, Sauer DA, Mace J, Smith TL. Relationship between clinical measures and histopathologic findings in chronic rhinosinusitis. Otolaryngol Head Neck Surg 2009; 141 (04) 454-461
- 15 Nakayama T, Yoshikawa M, Asaka D. et al. Mucosal eosinophilia and recurrence of nasal polyps - new classification of chronic rhinosinusitis. Rhinology 2011; 49 (04) 392-396
- 16 Lino WVS, Bachi ALL, Neto JAM, Caetani G, Amaral JBD, Pezato R. CD133, a progenitor cell marker, is reduced in nasal polyposis and showed significant correlations with TGF-β1 and IL-8. Int Arch Otorhinolaryngol 2021; 26 (01) e091-e096
- 17 Asghari M, Izadpanahi S, Esfahani MH. Comparison of blood and tissue eosinophil count and blood IgE in patients with chronic sinusitis and nasal polyps. J Immunol Res 2021; 2021: 6680676
- 18 Hastie AT, Moore WC, Li H. et al; National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects. J Allergy Clin Immunol 2013; 132 (01) 72-80
- 19 Ullmann N, Bossley CJ, Fleming L, Silvestri M, Bush A, Saglani S. Blood eosinophil counts rarely reflect airway eosinophilia in children with severe asthma. Allergy 2013; 68 (03) 402-406
- 20 Sreeparvathi A, Kalyanikuttyamma LK, Kumar M, Sreekumar N, Veerasigamani N. Significance of blood eosinophil count in patients with chronic rhinosinusitis with nasal polyposis. J Clin Diagn Res 2017; 11 (02) MC08-MC11
- 21 Han J, Wang W, Zhu Z. et al. Profile of tissue Immunoglobulin E in eosinophilic chronic rhinosinusitis with nasal polyps. Int Arch Allergy Immunol 2022; 183 (08) 835-842

